Podcast Episodes
Back to SearchSquawk on the Street 2ND Hour: 12/26/25
The second hour of CNBC’s "Squawk on the Street" with Carl Quintanilla and Sara Eisen is broadcast each weekday from the floor of the New York Stock Exchange, with the up-to-the-minute news investors…
Published on 16 hours ago
Record Highs and the Santa Claus Rally Watch, Metals Rock, Nvidia's $20B Deal 12/26/25
Brian Sullivan, Morgan Brennan and Dominic Chu discussed fresh record highs for the S&P 500, sparking investor hopes for a "Santa Claus rally." Gold, silver and platinum also hit new all-time highs. …
Published on 17 hours ago
SOTS 2nd Hour: Jeremy Siegel, Crypto’s Newest Lobbying Effort, Outlook for Pharam M&A 12/24/25
Wharton School Professor Jeremy Siegel reacts to this morning’s jobless claims number, plus lays out some under the radar risk to the market. Then Crypto’s latest lobbying effort isn’t such a new ide…
Published on 2 days, 17 hours ago
Santa Claus Rally, Nygren on Markets and WBD, Holiday Retail Homestretch 12/24/25
On the final trading day before Christmas, Carl Quintanilla and Melissa Lee explored Wall Street hopes for a "Santa Claus rally" one day after the S&P 500 hit a new record high. Oakmark Funds' Bill N…
Published on 2 days, 17 hours ago
Cramer’s Morning Take: Nvidia 12/23/25
Cramer says this semiconductor giant ‘should not be down.’ Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest …
Published on 3 days, 16 hours ago
SOTS 2nd Hour: Novo Nordisk Oral Weight-Loss Pill, Global Market Outlook, “Aggressive Housing Reform” 12/23/25
The FDA approving the first GLP-1 pill for obesity from Wegovy maker Novo Nordisk. CNBC speaking with the CEO about expanding access and how the pill will increase the company’s competitive edge. The…
Published on 3 days, 17 hours ago
FDA Approves Novo Nordisk's Wegovy Pill, ServiceNow CEO on $7.75B Deal, Q3 GDP Jumps 12/23/25
Carl Quintanilla and Jim Cramer led off show with the weight loss drug wars: Shares of Novo Nordisk shares surged after the FDA approved the company's Wegovy pill — making it the first oral GLP-1 cle…
Published on 3 days, 17 hours ago
Cramer’s Morning Take: Oracle 12/22/25
Cramer says he doesn’t want to ‘chase’ this software giant. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest…
Published on 4 days, 15 hours ago
Nvidia’s China Chip Shipments, Under-the-Radar Retail Metric, New State AI Laws 12/22/25
A new report says Nvidia could start shipping its H200 chip to China as soon as February, but some major roadblocks remain. Then a top wall street analyst says there is an under-the-radar indicator w…
Published on 4 days, 16 hours ago
Peltz's Trian Strikes a Deal, Paramount Amends WBD Offer, Nvidia and Tech Rise 12/22/25
Carl Quintanilla and Jim Cramer kicked off the holiday-shortened trading week with breaking news from Jim: Nelson Peltz's Trian Partners and General Catalyst to take asset manager Janus Henderson pri…
Published on 4 days, 17 hours ago